HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteoblastoma response to radiotherapy and chemotherapy.

Abstract
Osteoblastoma is a rare primary bone tumor that is curable by complete excision. There are few data about the effectiveness of chemotherapy or radiotherapy in the treatment of recurrent osteoblastoma. We report a 13-year-old girl wit recurrent osteoblastoma who, after in complete surgical excision, responded to treatment with radiotherapy and later with chemotherapy. Surgery remains the treatment of choice for osteoblastoma. Radiotherapy and chemotherapy either alone or together may be useful in selected patients with recurrent, aggressive tumor or in patients with surgically unresectable disease.
AuthorsS Berberoglu, A Oguz, E Aribal, O Ataoglu
JournalMedical and pediatric oncology (Med Pediatr Oncol) Vol. 28 Issue 4 Pg. 305-9 (Apr 1997) ISSN: 0098-1532 [Print] United States
PMID9078333 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Doxorubicin
  • Cisplatin
Topics
  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cervical Vertebrae
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Doxorubicin (administration & dosage)
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasm Recurrence, Local (drug therapy, pathology, radiotherapy, surgery)
  • Osteoblastoma (drug therapy, pathology, radiotherapy, surgery)
  • Reoperation
  • Spinal Neoplasms (drug therapy, pathology, radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: